This phase II trial determines if testing samples from a patients' cancer can be used to find
specific drugs or drug combinations that can help control their disease. The safety and
tolerability of the drug or drug combination is also to be studied. Another purpose is for
researchers to study tumor cells to try to learn why some people respond to a certain therapy
and others do not, and why some cancer drugs stop working.
Phase:
Phase 2
Details
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborators:
Genentech, Inc. Oregon Health and Science University